Failure analysis of infection persistence after septic revision surgery: a checklist algorithm for risk factors in knee and hip arthroplasty.


Journal

Archives of orthopaedic and trauma surgery
ISSN: 1434-3916
Titre abrégé: Arch Orthop Trauma Surg
Pays: Germany
ID NLM: 9011043

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 14 08 2019
pubmed: 17 4 2020
medline: 22 6 2021
entrez: 17 4 2020
Statut: ppublish

Résumé

Several studies describe risk factors for primary periprosthetic joint infection (PJI) and general treatment outcome factors like microbe spectrum or patient-specific risk factors. However, these general and patient dependent findings cannot solely explain all cases of infection persistence after a prior septic revision. This study analyzes possible specific and patient independent reasons for failure after revisions for PJI in knee and hip arthroplasty. In a prospective analysis all patients were included that were treated: (1) at our department, (2) with a two-stage exchange, (3) between 2013 and 2017, (4) due to an infection persistence after a previous revision for PJI. Possible reasons for infection persistence were identified using a checklist algorithm, based on international guidelines. 70 patients with infection persistence could be included (44 knee joints, 26 hip joints). The average age was 71 years, the CCI (Charlson Comorbidity Index) 2.8 and the ASA (American Society of Anesthesiologists) score 2.7. In 85% at least one possible reason for patient independent infection persistence could be identified analyzing the previous infection therapy: (1) 50% inadequate therapy concept (n = 35), (2) 33% inadequate surgical debridement (n = 23), (3) 30% inadequate antimicrobial therapy (n = 21), (4) 13% missed external bacterial primary focus (n = 9). After the individual failure analysis, all 70 patients were treated with a two-stage exchange in our department and in 94.9% infection freedom could be achieved (34.3 ± 10.9 months follow-up). In the majority of failed revisions with subsequent infection persistence at least one possible patient independent failure cause could be identified. The entire previous therapy should be critically reviewed following failing revisions to optimize the outcome of septic revisions. By using a checklist algorithm, high rates of infection freedom were achieved.

Identifiants

pubmed: 32296968
doi: 10.1007/s00402-020-03444-0
pii: 10.1007/s00402-020-03444-0
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

577-585

Références

Müller M, Trampuz A, Winkler T, Perka C (2018) The economic challenge of centralised treatment of patients with periprosthetic infections. Z Orthop Unfall 156(04):407–413
doi: 10.1055/s-0044-100732
Jiranek WA, Waligora AC, Hess SR, Golladay GL (2015) Surgical treatment of prosthetic joint infections of the hip and knee: changing paradigms? J Arthroplast 30(6):912–918
doi: 10.1016/j.arth.2015.03.014
Poultsides LA, Triantafyllopoulos GK, Sakellariou VI, Memtsoudis SG, Sculco TP (2018) Infection risk assessment in patients undergoing primary total knee arthroplasty. Int Orthop 42(1):87–94
doi: 10.1007/s00264-017-3675-z
Jämsen E, Nevalainen P, Eskelinen A, Huotari K, Kalliovalkama J, Moilanen T (2012) Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J Bone Jt Surg Am 94(14):e101
doi: 10.2106/JBJS.J.01935
Ochsner P, Borens O, Bodler P, Broger I, Maurer T, Nötzli H (2014) Diagnosis of infections of the musculoskeletal system. In: Infections of the musculoskeletal system. Basic principles, prevention, diagnosis and treatment. Swiss Orthopaedics and the Swiss Society for Infectious Diseases Expert Group, Grandvaux, Switzerland, pp 70–92
Krenn V, Morawietz L, Perino G, Kienapfel H, Ascherl R, Hassenpflug GJ, Thomsen M, Thomas P, Huber M, Kendoff D, Baumhoer D, Krukemeyer MG, Natu S, Boettner F, Zustin J, Kölbel B, Rüther W, Kretzer JP, Tiemann A, Trampuz A, Frommelt L, Tichilow R, Söder S, Müller S, Parvizi J, Illgner U, Gehrke T (2014) Revised histopathological consensus classification of joint implant related pathology. Pathol Res Pract 210(12):779–786. https://doi.org/10.1016/j.prp.2014.09.017 (Epub 2014 Oct 17)
doi: 10.1016/j.prp.2014.09.017 pubmed: 25454771
Diaz-Ledezma C, Higuera CA, Parvizi J (2013) Success after treatment of periprosthetic joint infection: a Delphi-based international multidisciplinary consensus. Clin Orthop Relat Res 471(7):2374–2382
doi: 10.1007/s11999-013-2866-1
Karczewski D, Winkler T, Perka C, Müller M (2018) The preoperative microbial detection is no prerequisite for the indication of septic revision in cases of suspected periprosthetic joint infection. Biomed Res Int 2018:1729605. https://doi.org/10.1155/2018/1729605 (eCollection 2018)
doi: 10.1155/2018/1729605 pubmed: 30035117 pmcid: 6032972
Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351(16):1645–1654
doi: 10.1056/NEJMra040181
Renz N, Trampuz A (2018) Pocket guide to diagnosis and treatment of periprosthtetic joint infection (PJI). ProImplant Foundation Webpage. https://www.pro-implant-foundation.org/news/news-archive/358-new-version-pg-pji . Accessed 20 May 2019
Karczewski D, Winkler T, Renz N, Trampuz A, Lieb E, Perka C, Müller M (2019) A standardized interdisciplinary algorithm for the treatment of prosthetic joint infections. Bone Jt J 101-B(2):132–139
doi: 10.1302/0301-620X.101B2.BJJ-2018-1056.R1
Jiranek WA, Hanssen AD, Greenwald AS (2006) Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Jt Surg Am 88-A:2487–2500
doi: 10.2106/JBJS.E.01126
Li C, Renz N, Trampuz A (2018) Management of periprosthetic joint infection. Hip Pelvis 30(3):138–146. https://doi.org/10.5371/hp.2018.30.3.138 (Epub 2018 Sep 4)
doi: 10.5371/hp.2018.30.3.138 pubmed: 30202747 pmcid: 6123506
Parvizi J, Gehrke T, Chen AF (2013) Proceedings of the international consensus on periprosthetic joint infection. Bone Jt J 95-B(11):1450–1452
doi: 10.1302/0301-620X.95B11.33135
Akgün D, Müller M, Perka C, Winkler T (2018) An often-unrecognized entity as cause of recurrent infection after successfully treated two-stage exchange arthroplasty: hematogenous infection. Arch Orthop Trauma Surg 138(9):1199–1206
doi: 10.1007/s00402-018-2972-3
Akgün D, Perka C, Trampuz A, Renz N (2018) Outcome of hip and knee periprosthetic joint infections caused by pathogens resistant to biofilm-active antibiotics: results from a prospective cohort study. Arch Orthop Trauma Surg 138(5):635–642
doi: 10.1007/s00402-018-2886-0
Bryan AJ, Abdel MP, Sanders TL, Fitzgerald SF, Hanssen AD, Berry DJ (2017) Irrigation and debridement with component retention for acute infection after hip arthroplasty: improved results with contemporary management. J Bone Jt Surg Am 99(23):2011–2018
doi: 10.2106/JBJS.16.01103
Narayanan R, Anoushiravani AA, Elbuluk AM, Chen KK, Adler EM, Schwarzkopf R (2018) Irrigation and debridement for early periprosthetic knee infection: is it effective? J Arthroplast 33(6):1872–1878
doi: 10.1016/j.arth.2017.12.039
Gbejuade HO, Lovering AM, Webb JC (2015) The role of microbial biofilms in prosthetic joint infections. A review. Acta Orthop 86(2):147–158
doi: 10.3109/17453674.2014.966290
Anagnostakos K, Meyer C (2019) Partial two-stage exchange at the site of periprosthetic hip joint infections. Arch Orthop Trauma Surg 139(6):869–876
doi: 10.1007/s00402-019-03180-0
Tautenhahn J, Bürger T, Lippert H (2004) The present state of vacuum sealing. Chirurg 75(5):492–497
doi: 10.1007/s00104-004-0844-6
Alcala-Marquez C, Torrealba R, Mehbod AA, Dawson JM, Dressel TD, Transfeldt EE (2018) Recurrent surgical site infections in the spine after treatment with the vacuum-assisted closure (VAC) system. Clin Spine Surg 31(8):351–355
doi: 10.1097/BSD.0000000000000668
Barth RE, Vogely HC, Hoepelman AIM, Peters EJG (2011) “To bead or not to bead?” Treatment of osteomyelitis and prosthetic joint-associated infections with gentamicin bead chains. Int J Antimicrob Agents 38(5):371–375
doi: 10.1016/j.ijantimicag.2011.03.008
Mariconda M, Ascione T, Balato G, Rotondo R, Smeraglia F, Costa GG, Conte M (2013) Sonication of antibiotic-loaded cement spacers in a two-stage revision protocol for infected joint arthroplasty. BMC Musculoskelet Disord 14:193
doi: 10.1186/1471-2474-14-193
Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284(5418):1318–1322
doi: 10.1126/science.284.5418.1318
Berdal JE, Skråmm I, Mowinckel P, Gulbrandsen P, Bjørnholt JV (2005) Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect 11(10):843–845
doi: 10.1111/j.1469-0691.2005.01230.x
Furustrand Tafin U, Trampuz A, Corvec S (2013) In vitro emergence of rifampicin resistance in Propionibacterium acnes and molecular characterization of mutations in the rpoB gene. J Antimicrob Chemother 68(3):523–528
doi: 10.1093/jac/dks428
Sendi P, Banderet F, Graber P, Zimmerli W (2011) Periprosthetic joint infection following Staphylococcus aureus bacteremia. J Infect 63(1):17–22
doi: 10.1016/j.jinf.2011.05.005
Murdoch DR, Roberts SA, Fowler VG Jr, Shah MA, Taylor SL, Morris AJ, Corey GR (2001) Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis 32(4):647–649
doi: 10.1086/318704
Tai T-W, Lin T-C, Ho C-J, Kao Yang Y-H, Yang C-Y (2016) Frequent dental scaling is associated with a reduced risk of periprosthetic infection following total knee arthroplasty: a nationwide population-based nested case-control study. PLoS One 11(6):e0158096
doi: 10.1371/journal.pone.0158096
Ntalos D, Berger-Groch J, Rohde H, Grossterlinden LG, Both A, Luebke A, Hartel MJ, Klatte TO (2019) Implementation of a multidisciplinary infections conference affects the treatment plan in prosthetic joint infections of the hip: a retrospective study. Arch Orthop Trauma Surg 139(4):467–473
doi: 10.1007/s00402-018-3079-6
Luessenhop CP, Higgins LD, Brause BD, Ranawat CS (1996) Multiple prosthetic infections after total joint arthroplasty. Risk factor analysis. J Arthroplast 11(7):862–868
doi: 10.1016/S0883-5403(96)80189-6
Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD (2016) Patient- related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. PLoS One 11(3):e0150866
doi: 10.1371/journal.pone.0150866

Auteurs

Sofia Kilgus (S)

Center for Musculoskeletal Surgery, Department of Orthopaedic Surgery, Charité-Universitaetsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Daniel Karczewski (D)

Center for Musculoskeletal Surgery, Department of Orthopaedic Surgery, Charité-Universitaetsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. daniel.karczewski@charite.de.

Cindy Passkönig (C)

Center for Musculoskeletal Surgery, Department of Orthopaedic Surgery, Charité-Universitaetsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Tobias Winkler (T)

Center for Musculoskeletal Surgery, Department of Orthopaedic Surgery, Charité-Universitaetsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Doruk Akgün (D)

Center for Musculoskeletal Surgery, Department of Orthopaedic Surgery, Charité-Universitaetsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Carsten Perka (C)

Center for Musculoskeletal Surgery, Department of Orthopaedic Surgery, Charité-Universitaetsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Michael Müller (M)

Center for Musculoskeletal Surgery, Department of Orthopaedic Surgery, Charité-Universitaetsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH